Nephrocare Health IPO GMP today stands at ₹42, showing steady momentum in the grey market. With a recent surge from ₹30 to ₹37 in just two days, investors are watching this closely. Stay updated with live IPO GMP today for the latest market pulse and signals.
Table of Contents
Nephrocare Health IPO GMP Live Movement Day Wise
| Date | IPO GMP | IPO Price | Estimated Listing Gain |
|---|---|---|---|
| 19 Dec 2025 | ₹40 | ₹460 | ₹500 (≈8.6%) |
| 18 Dec 2025 | ₹36 | ₹460 | ₹496 (≈7.8%) |
| 17 Dec 2025 | ₹42 ▲ | ₹460 | ₹502 (≈9.1%) |
| 16 Dec 2025 | ₹36 | ₹460 | ₹496 (≈7.8%) |
| 15 Dec 2025 | ₹38 ▲ | ₹460 | ₹498 (≈8.2%) |
| 14 Dec 2025 | ₹33 | ₹460 | ₹493 (≈7.1%) |
| 13 Dec 2025 | ₹37 ▲ | ₹460 | ₹497 (≈8.0%) |
| 12 Dec 2025 | ₹30 ▲ | ₹460 | ₹490 (≈6.5%) |
| 11 Dec 2025 | ₹20 ▲ | ₹460 | ₹480 (≈4.3%) |
Nephrocare Health IPO Dates Timeline
| Event | Date |
|---|---|
| IPO Open Date | 10 December 2025 |
| IPO Close Date | 12 December 2025 |
| Basis of Allotment | 15 December 2025 |
| Refunds Initiation | 16 December 2025 |
| Credit to Demat | 16 December 2025 |
| IPO Listing Date | 17 December 2025 |
| UPI Mandate Cut-off | 12 December 2025 – 5:00 PM |
Nephrocare Health IPO Review
| Rating | Review |
| ⭐⭐⭐ | Good |
Nephrocare Health IPO Overview
| Metric | Details |
|---|---|
| Total Issue Size | Approx ₹871.05 Crores |
| IPO Price Band | ₹438 – ₹460 per share |
| Minimum Investment | ₹14,720 (1 lot, 32 shares at upper band) |
| Lot Size | 32 shares per lot |
| Issue Type | Mainboard, Book Built Issue |
| IPO Listing | BSE & NSE |
| DRHP Draft Link | View |
Business Model Explained
Nephrocare Health is a specialized healthcare company focusing on kidney-related treatments and dialysis services across India. Founded with a mission to make renal care affordable and accessible, the company operates a growing network of nephrology clinics and dialysis centers. It offers services ranging from basic diagnostics to chronic kidney disease management. Their key offerings include in-center dialysis, peritoneal dialysis, home-based care, and telemedicine follow-ups.
Revenue is generated through patient care services, long-term treatment packages, tie-ups with insurance providers, and hospital partnerships. With a patient-first approach, Nephrocare Health stands out in the healthcare segment for combining advanced medical infrastructure with human-centric care. The Nephrocare Health IPO GMP buzz reflects its strong positioning in the rising renal care market. If you’re tracking live IPO GMP today, this one’s worth watching.
Strengths
Nephrocare Health IPO GMP gains traction due to the company’s niche healthcare focus and growing demand for kidney care. Its multi-location presence, tech-enabled services, and recurring patient base support consistent revenue and long-term growth appeal.
Weaknesses / Risks
Despite strong fundamentals, Nephrocare Health IPO GMP faces risks like competition from large hospitals and price-sensitive markets. Regulatory shifts, reliance on specialized staff, and regional expansion challenges may impact margins and scalability.
Popular Products from Nephrocare Health
Nephrocare Health provides essential kidney care services designed for patients needing long-term support. Their offerings include dialysis sessions, chronic kidney disease management, online consultations, and nutritional care. These services help patients live better with kidney conditions, offering regular checkups, advanced dialysis technology, and compassionate support. The company’s goal is to make quality nephrology treatment accessible and cost-effective for everyone, especially in tier-2 and tier-3 cities.
Nephrocare Health IPO GMP FAQs
What is the current GMP of Nephrocare Health IPO?
The Nephrocare Health IPO GMP today is ₹42 in the grey market, reflecting positive investor sentiment.
What are the expected returns?
Based on current Grey Market Premium trends, Nephrocare Health IPO is expected to deliver returns of around 28–30% on listing.
What is the IPO listing date?
The listing date for Nephrocare Health IPO is tentatively set for December 20, 2025, subject to final confirmation.
When does the IPO open and close?
Nephrocare Health IPO will open for subscription on December 12, 2025, and close on December 14, 2025.
